BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals
BioPharma Credit (BPCR.L) and BioPharma Credit Investments V signed a definitive senior-secured loan deal to each invest up to $100 million in US-based Tarsus Pharmaceuticals. The life sciences debt i
MT NewswiresApr 24 05:31 ET
Tarsus Pharmaceuticals Secures $75M Loan for Growth and Debt Repayment
TipRanksApr 23 08:52 ET
Express News | Tarsus Pharmaceuticals Inc: Strengthens Financial Position and Refinances Existing Debt With $200 Mln Non-Dilutive Financing Commitment From Pharmakon
Moomoo 24/7Apr 23 08:31 ET
Express News | Tarsus Strengthens Financial Position And Refinances Existing Debt With $200M Non-dilutive Financing Commitment From Pharmakon
Moomoo 24/7Apr 23 08:31 ET
Positive Signs As Multiple Insiders Buy Tarsus Pharmaceuticals Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), that sends out
Simply Wall StApr 23 06:30 ET
Form 144 | Tarsus Pharmaceuticals(TARS.US) Insider Proposes to Sell 912K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 11, $Tarsus Pharmaceuticals(TARS.US)$ Insider Trevejo Jose M. intends to sell 24,000 shares of its common stock on Apr 11, with a total market value of approximately $912K.
moomoo NewsApr 11 14:59 ET
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
Yahoo FinanceApr 4 11:33 ET
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
Yahoo FinanceApr 1 12:00 ET
Tarsus Pharmaceuticals Price Target Raised to $44.00/Share From $30.00 by Jefferies
Tarsus Pharmaceuticals Price Target Raised to $44.00/Share From $30.00 by Jefferies
Dow JonesMar 7 07:32 ET
Tarsus to Participate at Upcoming Investor Conferences
IRVINE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for
GlobeNewswireMar 5 16:30 ET
Tarsus Introduces "Mite Party" Campaign for XDEMVY (Lotilaner Ophthalmic Solution) 0.25% to Educate Consumers About Demodex Blepharitis
Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately 25 million eye care
GlobeNewswireMar 5 08:30 ET
Analysts Are Upgrading Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Latest Results
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) defied analyst predictions to release its full-year results, which were ahead of market expectations. Revenues of US$17m beat estimates by a substantial
Simply Wall StMar 1 13:34 ET
Tarsus Pharmaceuticals Stock Dips After Pricing $100M Securities Offering
Seeking AlphaMar 1 03:55 ET
Tarsus Offering Is Expected to Close March 5 >TARS
Tarsus Offering Is Expected to Close March 5 >TARS
Dow JonesMar 1 00:15 ET
Tarsus: Goldman Sachs, BofA Securities Among Managers for Offering >TARS
Tarsus: Goldman Sachs, BofA Securities Among Managers for Offering >TARS
Dow JonesMar 1 00:15 ET
Tarsus Offering Pre-funded Warrants to Buy Up to 312,500 Shares >TARS
Tarsus Offering Pre-funded Warrants to Buy Up to 312,500 Shares >TARS
Dow JonesMar 1 00:14 ET
Tarsus Offering 2,812,500 Shares of Common Stock at $32.00 Each >TARS
Tarsus Offering 2,812,500 Shares of Common Stock at $32.00 Each >TARS
Dow JonesMar 1 00:13 ET
Tarsus Announces Pricing of $100.0 Million Public Offering
IRVINE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) (the "Company" or "Tarsus"), whose mission is to focus on unmet needs and apply proven science and new technology to
GlobeNewswireMar 1 00:07 ET
Tarsus Pharmaceuticals Shares Fall 11% After Public Offering News
By Stephen Nakrosis Shares of Tarsus Pharmaceuticals were trading in the red in Thursday's after-hours session, following news the company commenced an underwritten public offering for $100 million o
WSJFeb 29 18:51 ET
Tarsus Pharmaceuticals Files for Automatic Mixed Securities Shelf
Seeking AlphaFeb 29 16:42 ET
No Data
No Data